Singapore, Jan 20, 2010: Omnicare Clinical Research and Clinimetrics Research Associates, both clinical research organizations (CROs) wholly owned by Omnicare, Inc., announced the launch of a joint global safety surveillance and pharmacovigilance solution. Global Safety Advantage provides clients with enhanced quality safety services delivered by a team of safety professionals worldwide.

Using the Oracle Adverse Event Reporting System (AERS), Global Safety Advantage offers clinical and post-marketing adverse event (AE) and serious adverse event (SAE) reporting from initial data collection to regulatory submission and beyond to post-marketing coverage.

The release noted that additionally, the program features value added services including, but not limited to, temporary staffing; consultation and assessment of safety systems/services; and establishment of database systems and Standard Operating Procedures (SOPs).

“By combining the resources of Omnicare Clinical Research and Clinimetrics in certain functional areas like Safety Surveillance and Pharmacovigilance, we can provide the market with a more robust global service offering,” said Dr. James M. Pusey, President and CEO of Omnicare Clinical Research.

“Clinimetrics and Omnicare Clinical Research have a talented group of safety surveillance and pharmacovigilance professionals who are energized by this structure and committed to exceeding client expectations,” said Matt Smith, President and CEO of Clinimetrics.